Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

Hiv Clinical Trial

Official title: HOPE in Action Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes

Status Recruiting

Clinical Trial Summary

This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

Clinical Trial Description

Previously, people with HIV in need of a transplant could only receive organs from a donor without HIV. However, in November 2013, the HIV Organ Policy Equity (HOPE) Act made it possible for people with HIV to receive organs from donors with HIV as a part of a research study.

Over the last two decades, people with HIV have received organs from donors without HIV, and in general, these recipients have done well after transplant and still maintained control of their HIV. Over the last several years, people with HIV have received organs from donors with HIV, and in general, these recipients have also done well after transplant and still maintained control of their HIV. This study will look to better understand rejection in transplant recipients with HIV (HIVR+) who receive kidneys from donors with HIV (HIVD+) vs without HIV (HIVD-). ;

Related Conditions & MeSH terms

• Hiv

• NCT number: NCT06263426
• Study type: Interventional
• Source: Johns Hopkins University
• Contact: Christine Durand, MD
• Phone: 410-614-6702
• Email: cdurand2@jhmi.edu
• Status: Recruiting
• Phase: N/A
• Start date: May 22, 2024
• Completion date: September 2029